Quick Ratios
Quarterly Results
Profit & Loss
Balance Sheet
Cash Flow
Ratios
Mkt Cap
Market Capitalization
₹1,011Cr
Rev Gr TTM
Revenue Growth TTM
6.91%
Peer Comparison
Compare up to 10 companies side by side across valuation, profitability, and growth.

BOROSCI
VS
| Quarter | Jun 2023 | Sep 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Mar 2025 | Jun 2025 | Sep 2025 |
|---|
|
Growth YoY Revenue Growth YoY% | | | | | 19.0 | 12.0 | 1.8 | 11.9 | -7.9 | 3.8 | 19.6 |
| 82 | 83 | 88 | 97 | 94 | 87 | 91 | 113 | 91 | 99 | 104 |
Operating Profit Operating ProfitCr |
| 6.5 | 10.3 | 12.2 | 15.8 | 9.4 | 15.4 | 9.9 | 12.8 | 5.1 | 7.5 | 14.2 |
Other Income Other IncomeCr | 1 | 1 | 1 | 1 | 2 | 2 | 2 | 3 | -4 | 2 | 1 |
Interest Expense Interest ExpenseCr | 1 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Depreciation DepreciationCr | 4 | 4 | 5 | 4 | 5 | 5 | 5 | 5 | 5 | 5 | 5 |
| 2 | 6 | 8 | 15 | 7 | 12 | 7 | 14 | -4 | 5 | 13 |
| -1 | 1 | 2 | 5 | 2 | 4 | 3 | 5 | 0 | 2 | 4 |
|
Growth YoY PAT Growth YoY% | | | | | 52.6 | 74.3 | -24.8 | -8.9 | -183.9 | -67.6 | 103.3 |
| 3.8 | 5.5 | 5.7 | 8.2 | 4.8 | 8.6 | 4.2 | 6.7 | -4.4 | 2.7 | 7.2 |
| 0.4 | 0.6 | 0.7 | 1.1 | 0.6 | 1.0 | 0.5 | 1.0 | -0.5 | 0.3 | 1.0 |
| Financial Year | Mar 2024 | Mar 2025 | TTM |
|---|
|
| | 10.7 | 3.5 |
| 349 | 386 | 407 |
Operating Profit Operating ProfitCr |
| 11.8 | 12.0 | 10.3 |
Other Income Other IncomeCr | 4 | 8 | 2 |
Interest Expense Interest ExpenseCr | 3 | 2 | 1 |
Depreciation DepreciationCr | 16 | 18 | 19 |
| 32 | 40 | 28 |
| 8 | 14 | 12 |
|
| | 13.8 | -40.3 |
| 5.9 | 6.1 | 3.5 |
| 2.6 | 3.0 | 1.8 |
| Financial Year | Mar 2024 | Mar 2025 | Sep 2025 |
|---|
Equity Capital Equity CapitalCr | 9 | 9 | 9 |
| 367 | 395 | 396 |
Current Liabilities Current LiabilitiesCr | 100 | 87 | 81 |
Non Current Liabilities Non Current LiabilitiesCr | 17 | 17 | 17 |
Total Liabilities Total LiabilitiesCr |
Current Assets Current AssetsCr | 291 | 310 | 300 |
Non Current Assets Non Current AssetsCr | 203 | 199 | 203 |
Total Assets Total AssetsCr |
| Financial Year | Mar 2024 | Mar 2025 |
|---|
Operating Cash Flow Operating Cash FlowCr | 30 | 120 |
Investing Cash Flow Investing Cash FlowCr | -2 | -115 |
Financing Cash Flow Financing Cash FlowCr | -16 | -3 |
|
Free Cash Flow Free Cash FlowCr | 17 | 106 |
| 127.8 | 449.2 |
CFO To EBITDA CFO To EBITDA% | 64.3 | 228.2 |
| Financial Year | Mar 2024 | Mar 2025 |
|---|
Valuation Ratios Valuation Ratios |
Market Cap Market CapitalizationCr | 0 | 1,086 |
Price To Earnings Price To Earnings | 0.0 | 40.6 |
Price To Sales Price To Sales | 0.0 | 2.5 |
Price To Book Price To Book | 0.0 | 2.7 |
| 0.1 | 20.6 |
Profitability Ratios Profitability Ratios |
| 63.5 | 63.2 |
| 11.8 | 12.0 |
| 5.9 | 6.1 |
| 8.7 | 10.0 |
| 6.3 | 6.6 |
| 4.8 | 5.3 |
Operational Ratios Operational Ratios |
Solvency Ratios Solvency Ratios |
Liquidity Ratios Liquidity Ratios |
### **Overview**
Borosil Scientific Limited (BSL) is India’s largest and most trusted manufacturer of laboratory glassware, with over **62 years of industry leadership** and a dominant market presence spanning scientific research, pharmaceuticals, education, and industrial sectors. Following its strategic demerger from Borosil Limited in December 2023, the company has emerged as a focused, independent entity dedicated exclusively to the scientific products segment. Listed on the BSE and NSE in June 2024, Borosil Scientific is now organized into four specialized divisions, enabling targeted investments, operational agility, and accelerated growth.
The company leverages deep-rooted brand credibility, indigenous R&D, advanced manufacturing, and a pan-India supply chain to drive innovation and support global demand for high-precision, regulatory-compliant scientific solutions.
---
### **Core Business Segments**
Borosil Scientific operates across four integrated verticals, forming a comprehensive portfolio tailored for laboratories, pharmaceuticals, research institutions, and industrial R&D:
1. **Laboratory Glassware & Consumables**
- Flagship business and market leader in India with over **65–67% market share**.
- Products: Volumetric flasks, pipettes, burettes, reagent bottles, beakers, test tubes, quartz ware, petri dishes, sintered glassware, desiccators, Soxhlet extractors, and filtration assemblies.
- Key innovation: **QR-coded Class A volumetric glassware** – laser engraved with UID/QR codes for digital calibration certificate access and LIMS integration.
- Manufacturing: State-of-the-art Bharuch plant produces **over 45,000 units daily**, supported by automation, in-house NABL-accredited calibration labs, IoT-enabled monitoring, and a 33,000+ sq. ft. warehouse.
- Market presence: Supplies **75% of lab glassware used in Indian labs**; exports reach over **90 countries**.
2. **Laboratory Equipment (LabQuest Brand)**
- Growth engine with **32.3% YoY revenue rise** (FY24–25: ₹42.3 Cr from ₹31.9 Cr).
- Product Range: Nitrogen estimation systems, water/dry baths, stirrers, vortex mixers, bottle top dispensers, Kjeldahl units, centrifuges, heating mantles, photometers, moisture analysers, and e-Titrate systems.
- Innovation: Patented **Bottle Top Dispenser** (over 8,000 sold in 3 years), recently launched **e-dispenser**, micro vials, and automated liquid handling tools.
- Focus areas: Life Sciences, Nutrition & Environmental Sciences, Liquid Handling, and Pharma QA/QC.
- Pune-based **Laboratory Instrumentation Excellence Center (36,000 sq. ft.)** houses R&D, advanced prototyping, electronics testing, and assembly lines.
3. **Pharmaceutical Primary Packaging**
- Manufacturer of **USP Type I borosilicate glass** vials and ampoules for injectables, vaccines, biologics, ophthalmic, dental, and analytical use.
- Product specifications:
- Ampoules: 1 ml to 50 ml
- Tubular Vials: 1 ml to 100 ml (including micro vials)
- Customization: Shape, size, color, and surface treatment (including siliconized vials).
- Regulatory compliance: Provides **extractables data (USP 232/233)** and **de-lamination reports (USP 1660)** using premium Schott glass tubing.
- Facilities: Nashik plant with **ISO Class 8 cleanroom**, servo automation, hot-end camera inspection.
- Capacity: **Over 400 million vials/year**, **800 million ampoules/year**.
- Sales: ₹68.5 crore in FY24–25; ₹64.59 crore in FY23–24.
- Expansion plans: Pre-filled syringes, cartridges, droppers, larger OD vials, vial inserts.
4. **Process Systems (Process Science Division)**
- Launched post-acquisition of **Goel Scientific Glass Works Limited (GSGWL)**, adding end-to-end capabilities in custom reactor design, pilot plants, and industrial distillation systems.
- Products: Bench-top reactors, jacketed glass reactors, automated reaction assemblies, mini-plants, wiped film evaporators, rotary evaporators.
- Applications: Chemical synthesis, process development, scale-up in pharma, biotech, and defense.
- Vadodara facility designs and manufactures **glass reactors up to 500 liters**.
- Services: Full lifecycle support including custom engineering, PLC automation, data logging, installation, and training.
- Sales: Grew **17.8% YoY** to ₹48.8 crores in FY24–25 (from ₹41.5 Cr).
---
### **Strategic Growth Drivers**
#### 1. **Diversification & Vertical Expansion**
- Shifted from lab glassware-centric model to an **integrated scientific solutions provider** spanning consumables, instruments, pharma packaging, and process systems.
- Entered **filter paper category** to expand scientific consumables footprint.
- Launched **new product lines** in water analysis (e.g., handheld photometer, moisture analyser), food safety, and biotech instrumentation.
#### 2. **Acquisitions & Integration**
- **Acquisition of Goel Scientific Glass Works Ltd (GSGWL):**
- Adds expertise in **chemical process systems, pilot plants, and large-scale industrial glassware**.
- Enables **import substitution** in high-end lab and industrial equipment.
- Strengthens domestic manufacturing under **Make in India / Atmanirbhar Bharat**.
- **Acquisition of Klasspack Pvt. Ltd. (2016):** Expanded pharma packaging footprint via the Nashik facility.
#### 3. **Operational Excellence & Technology**
- **Automation & IoT:** Bharuch plant uses real-time IoT monitoring; targeting **TPM certification by 2027**.
- **Digital Transformation:** SAP HANA for ERP; Salesforce for CRM and sales force efficiency.
- **Advanced Manufacturing:** In-house calibration labs, laser marking, computer-controlled glass blowing, servo-driven handling, European machinery.
- **AI & Data Readiness:** Exploring AI applications in R&D, demand forecasting, and production optimization.
#### 4. **R&D & Innovation**
- Patented products: QR-coded glassware, LabQuest bottle top dispenser, e-dispenser, modular distillation units.
- Over **100 skilled glassblowers**, 45+ design engineers, and NABL-accredited labs across facilities.
- Invests in **homegrown innovation** for global markets—e.g., cost-competitive alternatives to imported equipment.
#### 5. **Market Expansion & Global Reach**
- **Exports to over 90 countries** across North America, Europe, Middle East, Africa, and Southeast Asia.
- Strong **OEM collaborations** and distributor network enhance global penetration.
- Targeted entry into **high-growth regions**: USA, EU, Africa, ASEAN.
- Benefits from **"China Plus One" strategy**—positioned as reliable alternative for global scientific infrastructure.
---
### **Customer & Supply Chain Strength**
- **Pan-India delivery in 24 hours** with **95–96% success rate** via four strategically located warehouses (Bharuch, Ghaziabad, Chennai, Kolkata).
- Distributor network: **150+ channel partners**.
- Sales & Service: **100+ professionals**, **80+ sales ambassadors** providing technical support.
- Key clients:
- **Pharma & Biotech:** Global leaders in injectables, CROs, CDMOs.
- **Academia & Research:** IITs, IICT, CCMB, ICT.
- **Industries:** Chemical, food & beverage, agriculture, defense, environmental agencies.
---
### **Strategic Positioning**
- **Market Leadership:** #1 in lab glassware in India; emerging leader in pharma packaging and process equipment.
- **One-Stop Shop:** Offers **4,000+ SKUs** across four verticals—rare in Indian scientific manufacturing.
- **Import Substitution Champion:** Provides **Indian-made, global-standard alternatives** in high-tech lab and industrial equipment.
- **Aligned with Megatrends:**
- Post-pandemic R&D revival
- Digital procurement (Government e-Marketplace)
- Global supply chain diversification (China +1)
- Rise in pharma & biotech innovation, especially in biosimilars, vaccines, and personalized medicine